Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Black Diamond Therapeutics
About
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.
- Cambridge,Massachusetts,United States
- https://www.blackdiamondtherapeutics.com/
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $85M
- Industries
- Biotechnology,Life Science,Medical
- Founded date
- Jan 1, 2017
- Operating Status
- Active
- Stock Symbol
- nasdaq:BDTX
- Legal Name
- Black Diamond Therapeutics, Inc.
- Also Known As
- Aset Therapeutics
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small-molecule. It is engaged in discovering and developing small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, Mutation-Allostery-Pharmacology, which targets cancer mutations.Black Diamond focuses on the discovery and development of precision medicines for cancer that are directed against a novel class of allosteric mutant oncogenes. It also targets undrugged mutations in patients with genetically defined cancers for whom limited treatment options currently exist. It is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 29, 2022 | Series Unknown | $10M | — | — | — | Detail |
| Jan 29, 2020 | IPO | $231.30M | — | — | — | Detail |
| Dec 5, 2019 | Series C | $85M | 13 |
Boxer Capital
|
— | Detail |
| Jan 9, 2019 | Series B | $85M | 14 |
Boxer Capital
New Enterprise Associates
RA Capital Management
|
— | Detail |
| Dec 12, 2018 | Series A | $20M | 1 |
Versant Ventures
|
— | Detail |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 12, 2022
Launchpad Therapeutics
|
Series A | $30M | Life Science | — |
|
Feb 8, 2021
Goody
|
Seed | $4M | Consumer | — |
|
Mar 25, 2020
Helm.ai
|
Seed | $13M | Artificial Intelligence | — |
|
Apr 18, 2019
Fuzzbuzz
|
Seed | $2.70M | Developer Tools | — |
|
Aug 4, 2016
Elation Health
|
Series B | $15M | Electronic Health Record (EHR) | — |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Boxer Capital
|
Yes | Series C |
BVF Partners
|
— | Series C |
City Hill Ventures
|
— | Series C |
|
|
— | Series C |
Invus
|
— | Series C |
|
|
— | Series C |
|
New Enterprise Associates
|
— | Series C |
|
|
— | Series C |
Perceptive Advisors
|
— | Series C |
|
RA Capital Management
|
— | Series C |
Employee Profiles
